Patent ID: 6063363
Filing Date: 2000-05-16
Classification: A61K,Y10S

Abstract:
A method for treating an upper respiratory tract infection comprising the step of applying to affected nasal passages, throat or lungs a composition in the form selected from the group consisting of liquid solution, aerosols, emulsions, ointment, lozenge and gel preparation, said composition consisting essentially of a potassium salt in a pharmaceutically acceptable carrier, said potassium salt being present from about 0.1 to about 3.0 percent of the composition by weight, and wherein said potassium salt is selected from the group consisting of potassium acetate, potassium aluminate, potassium arsenite solution, potassium bicarbonate, potassium bisulfate, potassium bitartarate, potassium bromide, potassium carbonate, potassium chloride, potassium citrate, potassium glucontate, potassium glycerophosphate, potassium iodate, potassium iodide, potassium manganate, potassium permanganate, potassium phosphate monobasic, potassium phosphate dibasic, potassium phosphate tribasic and potassium phosphite.